Polycystic Ovary Syndrome
"Polycystic Ovary Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A complex disorder characterized by infertility, HIRSUTISM; OBESITY; and various menstrual disturbances such as OLIGOMENORRHEA; AMENORRHEA; ANOVULATION. Polycystic ovary syndrome is usually associated with bilateral enlarged ovaries studded with atretic follicles, not with cysts. The term, polycystic ovary, is misleading.
| Descriptor ID |
D011085
|
| MeSH Number(s) |
C04.182.612.765 C13.351.500.056.630.580.765 C19.391.630.580.765
|
| Concept/Terms |
Polycystic Ovary Syndrome- Polycystic Ovary Syndrome
- Ovary Syndrome, Polycystic
- Syndrome, Polycystic Ovary
- Stein-Leventhal Syndrome
- Stein Leventhal Syndrome
- Syndrome, Stein-Leventhal
- Sclerocystic Ovarian Degeneration
- Ovarian Degeneration, Sclerocystic
- Sclerocystic Ovary Syndrome
- Polycystic Ovarian Syndrome
- Ovarian Syndrome, Polycystic
- Polycystic Ovary Syndrome 1
|
Below are MeSH descriptors whose meaning is more general than "Polycystic Ovary Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Polycystic Ovary Syndrome".
This graph shows the total number of publications written about "Polycystic Ovary Syndrome" by people in this website by year, and whether "Polycystic Ovary Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 1 | 2 |
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 2 | 0 | 2 |
| 2022 | 2 | 0 | 2 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Polycystic Ovary Syndrome" by people in Profiles.
-
Sama SR, Gore R, Bauer AZ, Garber L, Rosiello R, Sundaresan D, McDonald A, Kriebel D. Targeting patients for early COVID-19 therapy; Pre-infection metabolic dysfunction, polycystic ovary syndrome and risk of severe disease in patients under 65: A Massachusetts community-based observational study. PLoS One. 2023; 18(6):e0287430.
-
Riepsamen AH, Donoghoe MW, Indran IR, Hechtman L, Robertson DM, Gilchrist RB, Ledger WL, Yong EL. Serum GDF9 and BMP15 as potential markers of ovarian function in women with and without polycystic ovary syndrome. Clin Endocrinol (Oxf). 2023 04; 98(4):567-577.
-
Joshi A, Aluko A, Styer AK, Young BC, Johnson KM, Hacker MR, Modest AM. PCOS and the risk of pre-eclampsia. Reprod Biomed Online. 2022 11; 45(5):961-969.
-
Kovell LC, Juraschek SP, Michos ED. Hypertension in Young Women: Implications of the Polycystic Ovary Syndrome and Opportunities for Prevention and Further Research. J Clin Endocrinol Metab. 2021 08 18; 106(9):e3775-e3777.
-
Vagios S, Sacha CR, Hammer KC, Dimitriadis I, James KE, Bormann CL, Souter I. Response to ovulation induction treatments in women with polycystic ovary syndrome as a function of serum anti-M?llerian hormone levels. J Assist Reprod Genet. 2021 Jul; 38(7):1827-1833.
-
Vagios S, James KE, Sacha CR, Hsu JY, Dimitriadis I, Bormann CL, Souter I. A patient-specific model combining antim?llerian hormone and body mass index as a predictor of polycystic ovary syndrome and other oligo-anovulation disorders. Fertil Steril. 2021 01; 115(1):229-237.
-
Riepsamen AH, Chan K, Lien S, Sweeten P, Donoghoe MW, Walker G, Fraison EHJ, Stocker WA, Walton KL, Harrison CA, Ledger WL, Robertson DM, Gilchrist RB. Serum Concentrations of Oocyte-Secreted Factors BMP15 and GDF9 During IVF and in Women With Reproductive Pathologies. Endocrinology. 2019 10 01; 160(10):2298-2313.
-
Jalnapurkar I, Findley JC. A case of repeated mixed mood episodes with psychotic symptoms associated with the premenstrual period in a patient with polycystic ovarian syndrome. Gynecol Endocrinol. 2018 Jun; 34(6):467-469.
-
Merkin SS, Phy JL, Sites CK, Yang D. Environmental determinants of?polycystic ovary syndrome. Fertil Steril. 2016 07; 106(1):16-24.
-
Younis A, Hawkins K, Mahini H, Butler W, Garelnabi M. Serum tumor necrosis factor-a, interleukin-6, monocyte chemotactic protein-1 and paraoxonase-1 profiles in women with endometriosis, PCOS, or unexplained infertility. J Assist Reprod Genet. 2014 Nov; 31(11):1445-51.